Skip to content

Rick J. Strassman

20 papers in the library · 3,459 citations · publishing 1984-2026

Papers

Sort Most recent Most cited

5-HT1A receptor blockade potentiates the subjective effects of DMT.

Journal of Psychopharmacology May 2, 2026 Zarmeen Zahid, Rick J. Strassman, Clifford Qualls et al.

Serotonergic psychedelics are being investigated in the treatment of various disorders and in the improvement of well-being. Evidence suggests that their subjective effects may play a role in long-term behavioral outcomes. The subjective effects are mediated by 5-HT2A receptor agonism, but the 5-HT1A receptor may also play a role in the subjective effects. This study elucidates the effects of...

The Hallucinogen Rating Scale: Updated Factor Structure in a Large, Multistudy Sample.

Biological Psychiatry Global Open Science March 1, 2025 Abigail E. Calder, Clifford Qualls, Gregor Hasler et al. 5 citations

The Hallucinogen Rating Scale (HRS) has been widely used to measure the subjective effects of psychedelics and other psychoactive substances. Its advantages include a basis in phenomenological interviews and clinical studies, straightforward items, and broad coverage of psychedelic effects. Previous studies have attempted to resolve its factor structure but were limited by small samples of...

DOI: 10.1016/j.bpsgos.2024.100436 (opens in new tab) Full text (opens in new tab) Consciousness studies Psychedelics hallucinogens Entheogens Psychometrics measurement +8

Ketamine Pharmacodynamics Entangled: Comment.

Anesthesiology December 1, 2022 T. Andrew Bowdle, Nathan Sackett, Rick J. Strassman et al. 5 citations

We read with interest the study of ketamine psychedelic and analgesic effects by Olofsen et al.1 and the accompanying editorial by Mashour.2 In both articles, the authors refer to the “dissociative” effects of ketamine. Corssen and Domino3 originally used the term “dissociative” in 1966 to describe “patients and subjects who, during recovery from CI-581 [ketamine], felt as though they were in...

DOI: 10.1097/aln.0000000000004349 (opens in new tab) Ketamine Mechanism of action Therapeutic effects Neuroscience research

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain.

Scientific Reports June 27, 2019 Jon G Dean, Tiecheng Liu, Sean Huff et al. 111 citations

N,N-dimethyltryptamine (DMT), a psychedelic compound identified endogenously in mammals, is biosynthesized by aromatic-L-amino acid decarboxylase (AADC) and indolethylamine-N-methyltransferase (INMT). Whether DMT is biosynthesized in the mammalian brain is unknown. We investigated brain expression of INMT transcript in rats and humans, co-expression of INMT and AADC mRNA in rat brain and...

The psychedelic religion of mystical consciousnessReviews

Journal of Psychedelic Studies May 10, 2018 Rick J. Strassman 9 citations

With an extreme range of terms for psychedelic drugsfrom "schizotoxic" to "entheogenic" -"psychedelic," nonetheless remains the most salient one.These substances manifest or disclose aspects of the mind of those who take them as well as the mind of those who study them.Proponents for the innumerable terms for these drugs are all able to adduce supportive evidence.Necessarily, this evidence is a...

Psychological and neuropsychological assessment of regular hoasca users.

Comprehensive Psychiatry November 1, 2016 Paulo César Ribeiro Barbosa, Rick J. Strassman, Dartiu Xavier Da Silveira et al. 104 citations

Hoasca (also called ayahuasca) is a N,N-dimethyltryptamine (DMT) - containing psychedelic brew originally used for magico-religious purposes by Amerindian populations of the Amazon Basin. Recently, Brazilian syncretic churches have helped spread the ritual use of hoasca to Western societies. The aim of this study was to evaluate substance use, and neuropsychological and psychological...

A Model for the Application of Target-Controlled Intravenous Infusion for a Prolonged Immersive DMT Psychedelic Experience.

Frontiers in Pharmacology 2016 Andrew R. Gallimore, Rick J. Strassman 51 citations

The state of consciousness induced by N,N-dimethyltryptamine (DMT) is one of the most extraordinary of any naturally-occurring psychedelic substance. Users consistently report the complete replacement of normal subjective experience with a novel "alternate universe," often densely populated with a variety of strange objects and other highly complex visual content, including what appear to be...

Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study

Journal of Psychopharmacology January 13, 2015 Michael P. Bogenschutz, Alyssa A. Forcehimes, Jessica Pommy et al. 1,164 citations

Several lines of evidence suggest that classic (5HT2A agonist) hallucinogens have clinically relevant effects in alcohol and drug addiction. Although recent studies have investigated the effects of psilocybin in various populations, there have been no studies on the efficacy of psilocybin for alcohol dependence. We conducted a single-group proof-of-concept study to quantify acute effects of...

DOI: 10.1177/0269881114565144 (opens in new tab) Psilocybin Alcohol Hallucinogen Proof of concept

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.

Drug Testing and Analysis 2012 Steven A. Barker, Ethan H. Mcilhenny, Rick J. Strassman 143 citations

Three indole alkaloids that possess differing degrees of psychotropic/psychedelic activity have been reported as endogenous substances in humans; N,N-dimethyltryptamine (DMT), 5-hydroxy-DMT (bufotenine, HDMT), and 5-methoxy-DMT (MDMT). We have undertaken a critical review of 69 published studies reporting the detection or detection and quantitation of these compounds in human body fluids. In...

DOI: 10.1002/dta.422 (opens in new tab) Full text (opens in new tab) Endogenous psychedelics Natural psychedelics Internal psychedelics Bodily psychedelics +18

Health status of ayahuasca users.

Drug Testing and Analysis 2012 Paulo César Ribeiro Barbosa, Suely Mizumoto, Michael P. Bogenschutz et al. 112 citations

Ayahuasca is a psychedelic brew originally used for magico-religious purposes by Amerindian populations of the western Amazon Basin. Throughout the last four decades, the use of ayahuasca spread towards major cities in all regions of Brazil and abroad. This trend has raised concerns that regular use of this N,N-dimethyltryptamine- and harmala-alkaloid-containing tea may lead to mental and...

DOI: 10.1002/dta.1383 (opens in new tab) Full text (opens in new tab) Ayahuasca Traditional brew Psychedelic Plant medicine +14

Hallucinogen Rating Scale (HRS) - Versão brasileira: tradução e adaptação transcultural

Archives of Clinical Psychiatry (São Paulo) 2011 Suely Mizumoto, Dartiu Xavier Da Silveira, Paulo César Ribeiro Barbosa et al. 14 citations

BACKGROUND: There is a growing scientific interest in the effects of hallucinogens in general and the religious use of psychoactive brew ayahuasca in Brazil in particular. However, there is not yet a standard instrument used in Brazil to evaluate the effects of hallucinogens. The Hallucinogen Rating Scale (HRS) is a questionnaire widely used in the U.S. and Europe to evaluate the effects of...

Direct analysis of psychoactive tryptamine and harmala alkaloids in the Amazonian botanical medicine ayahuasca by liquid chromatography-electrospray ionization-tandem mass spectrometry.

Journal of Chromatography A December 18, 2009 Ethan H. Mcilhenny, Kelly E Pipkin, Leanna J Standish et al. 58 citations

A direct injection/liquid chromatography-electrospray ionization-tandem mass spectrometry procedure has been developed for the simultaneous quantitation of 11 compounds potentially found in the increasingly popular Amazonian botanical medicine and religious sacrament ayahuasca. The method utilizes a deuterated internal standard for quantitation and affords rapid detection of the alkaloids by a...

DOI: 10.1016/j.chroma.2009.10.088 (opens in new tab) Full text (opens in new tab) Ayahuasca Analytical chemistry Mass spectrometry Psychoactive compounds

A six-month prospective evaluation of personality traits, psychiatric symptoms and quality of life in ayahuasca-naïve subjects.

Journal of Psychoactive Drugs September 1, 2009 Paulo César Ribeiro Barbosa, Irene Maurício Cazorla, Joel Sales Giglio et al. 113 citations

The authors assessed 23 subjects immediately before and six months (27.5 weeks) after their first ayahuasca experience in an urban Brazilian religious setting, either Santo Daime (N = 15) or União do Vegetal (N = 8). Measures included scores on instruments assessing psychiatric symptoms, personality variables and quality of life. Independent variables were the frequency of ayahuasca use...

DOI: 10.1080/02791072.2009.10400530 (opens in new tab) Full text (opens in new tab) Ayahuasca ceremonial experience Single experience Frequent use Personality +11

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

Journal of Ethnopharmacology April 26, 2007 Rafael G. Dos Santos, J. Landeira-Fernández, Rick J. Strassman et al. 206 citations

The use of the hallucinogenic brew ayahuasca, obtained from infusing the shredded stalk of the malpighiaceous plant Banisteriopsis caapi with the leaves of other plants such as Psychotria viridis, is growing in urban centers of Europe, South and North America in the last several decades. Despite this diffusion, little is known about its effects on emotional states. The present study...

Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up.

Journal of Substance Abuse Treatment December 1, 2002 Evgeny Krupitsky, Andrey Burakov, Tatyana N. Romanova et al. 240 citations

Seventy detoxified heroin-addicted patients were randomly assigned to one of two groups receiving ketamine psychotherapy (KPT) involving two different doses of ketamine. The patients of the experimental group received existentially oriented psychotherapy in combination with a hallucinogenic ("psychedelic") dose of ketamine (2.0 mg/kg im). The patients of the control group received the same...

Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans

Biological Psychiatry May 1, 1996 Rick J. Strassman, Clifford Qualls, Laura M. Berg 129 citations

Tolerance of the behavioral effects of the short-acting, endogenous hallucinogen, N,N-dimethyltryptamine (DMT) is seen inconsistently in animals, and has not been produced in humans. The nature and time course of responses to repetitive, closely spaced administrations of an hallucinogenic dose of DMT were characterized. Thirteen experienced hallucinogen users received intravenous 0.3 mg/kg DMT...

DOI: 10.1016/0006-3223(95)00200-6 (opens in new tab) Differential mechanical device Differential effects Pharmacology

Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil

The Journal of Nervous and Mental Disease February 1, 1996 Charles S. Grob, Dennis J. Mckenna, James C. Callaway et al. 333 citations

A multinational, collaborative, biomedical investigation of the effects of hoasca (ayahuasca), a potent concoction of plant hallucinogens, was conducted in the Brazilian Amazon during the summer of 1993. This report describes the psychological assessment of 15 long-term members of a syncretic church that utilizes hoasca as a legal, psychoactive sacrament as well as 15 matched controls with no...

Human psychopharmacology of N,N-dimethyltryptamine

Behavioural Brain Research December 1, 1995 Rick J. Strassman 257 citations

We generated dose-response data for the endogenous and ultra-short-acting hallucinogen, N,N-dimethyltryptamine (DMT), in a cohort of experienced hallucinogen users, measuring multiple biological and psychological outcome measures. Subjective responses were quantified with a new rating scale, the HRS, which provided better resolution of dose effects than did the biological variables. A tolerance...

Hallucinogenic Drugs in Psychiatric Research and Treatment Perspectives and Prospects

The Journal of Nervous and Mental Disease March 1, 1995 Rick J. Strassman 90 citations

Clinical research with hallucinogens has resumed after a generation's hiatus. To place these new studies in context, this article reviews the history of hallucinogens' use and abuse, discusses their pharmacological properties, and highlights previous human studies. Research with lysergic acid diethylamide and related hallucinogens with thousands of patients and control subjects was associated...

ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE

The Journal of Nervous and Mental Disease October 1, 1984 Rick J. Strassman 315 citations

The use of naturally occurring and synthetically derived compounds for their "psychedelic" effects has been a part of human culture for thousands of years. The basic pharmacology of the major synthetic psychedelic compounds (primarily lysergic acid diethylamide [LSD]-25) is described and reference is made to their potentially beneficial psychological effects. Adverse reactions, defined as...

DOI: 10.1097/00005053-198410000-00001 (opens in new tab) Lysergic acid diethylamide Dysfunctional family Adverse effect Hallucinogen +2